US - Global animal health specialists, Pfizer, launched a new poultry health division at the International Poultry Exposition in Atlanta.
DURHAM, N.C.--The move follows the takeover of Embrex by Pfizer last
year.
The new poultry health division is designed to improve health
productivity and costs in the poultry industry. Pfizer said that the
Poultry Health Division will aim to improve their current products while
developing new and integrated poultry health solutions.
The division will aim to provide science, solutions, service and
success, said Jim Gerardot group director of global marketing.
"Pfizer is excited about delivering innovative poultry health solutions."
Joyce Lee, Pfizer vice president of the poultry health division said
that the acquisition of Embrex showed a significant commitment by Pfizer
to the poultry health industry.
She said that while Pfizer already had more than 200 products in the
pipeline, together with Embrex, the company was committed to furthering
research and development.
Embrex, founded in 1985, is an international biotechnology company
focused on developing biological and mechanical in ovo products
to improve bird health.
Embrex is noted for the development of an automated machine, Inovoject,
used to vaccinate chicks in ovo by delivering precise, uniform
injections ensuring accurate dosage to all eggs.
